Idenix, Gilead To Battle Over Hepatitis IP At Trial
Gilead Sciences Inc. and Idenix Pharmaceuticals Inc. told a Delaware federal judge Wednesday they are set to tangle over a patent related to a Hepatitis C treatment at a trial starting...To view the full article, register now.
Already a subscriber? Click here to view full article